• (301) 755-2600 |
  • (301) 754-1200
  • Book Appointment
Understanding AMD

What Is Age-Related Macular Degeneration

Schedule Today

(301) 754-1200
(301) 754-1200 Book Appointment
Rectangle 24
Rectangle 25

Understanding AMD

AMD affects the macula, the small central area of the retina responsible for sharp, detailed vision. When the macula breaks down, everyday tasks like reading, driving, and recognizing faces become increasingly difficult, even though side vision usually stays intact.

The macula handles the fine detail in everything you look at directly. As AMD develops, you may notice blurring in the center of your vision, distorted straight lines, or a dark or empty spot that grows over time. Your peripheral, or side, vision is generally not affected.

There are two main forms of AMD, and understanding the difference matters for treatment. Dry AMD is the more common form, affecting the large majority of people with the condition. It involves the buildup of small protein and fat deposits called drusen beneath the retina and a gradual thinning of the macula over time.

Wet AMD, also called neovascular AMD, is less common but causes more rapid and severe vision loss. In wet AMD, abnormal blood vessels grow beneath the retina and leak fluid or blood, which can quickly distort or destroy central vision. Some people with dry AMD develop wet AMD as their disease progresses.

AMD is one of the leading causes of legal blindness in adults aged 60 and older in the United States. Nearly 2 million Americans have advanced AMD, and that number is expected to grow significantly in the coming decades as the population ages. Globally, the number of people affected by AMD is projected to reach hundreds of millions by 2040.

Who Is at Risk for AMD

Who Is at Risk for AMD

Some risk factors for AMD are outside your control, while others are directly influenced by daily habits and health choices. Knowing where you stand can help guide both prevention and early detection.

Age is the most significant risk factor, with the risk rising steadily after age 55. A family history of AMD increases your personal risk considerably, and certain genetic variants are linked to the majority of advanced AMD cases. People of Northern European ancestry tend to develop AMD at higher rates than other populations.

Cigarette smoking is the strongest preventable risk factor, roughly doubling the likelihood of developing AMD. Other controllable factors include obesity, a diet low in leafy vegetables and fish, physical inactivity, and poorly managed cardiovascular conditions such as high blood pressure. Making changes in these areas can reduce your risk even if your age or genetics place you in a higher-risk group.

Early AMD causes no symptoms at all, which is why regular eye exams are so important. Comprehensive dilated eye exams are recommended for adults over 55, and annual exams are the standard for those 60 and older. If you smoke or have a family history of AMD, earlier and more frequent monitoring may be recommended by your eye doctor.

How AMD Is Diagnosed and Staged

How AMD Is Diagnosed and Staged

A thorough eye examination combined with advanced imaging gives your eye doctor a complete picture of your macular health. These tools help confirm a diagnosis, determine the stage of AMD, and guide the right treatment approach for you.

During a dilated eye exam, your eye doctor examines the retina directly after widening your pupil with special drops. Optical coherence tomography (OCT), a non-invasive imaging technology, creates detailed cross-section pictures of your retina that show drusen deposits, fluid accumulation, and structural damage that would not be visible otherwise. In some cases, a fluorescein angiography test, which uses a special dye to highlight blood vessels in the eye, is used to evaluate wet AMD.

AMD is categorized into three stages that help determine the right course of care.

  • Early AMD involves small to medium drusen with no noticeable vision changes
  • Intermediate AMD involves larger drusen or pigment changes in the retina, sometimes causing mild blurring
  • Late AMD involves significant central vision loss from either advanced dry AMD (geographic atrophy, where patches of retinal cells die off) or wet AMD

Your stage determines which treatments or monitoring strategies your eye doctor will recommend. Not everyone progresses through every stage, and the timeline varies significantly from person to person.

Eye care guidelines for AMD have been updated in recent years to reflect newly approved therapies and refined monitoring standards. Your eye doctor follows these current guidelines when determining how often you need to be seen, when to begin treatment, and how to track changes in your condition over time.

Treatment Options for AMD

There is no cure for AMD, but several treatments have been proven to slow its progression or reduce vision loss. The right approach depends on your AMD stage and the specific form you have. Your eye doctor will help you understand which options are appropriate for your situation.

For people with intermediate AMD, a specific nutritional supplement formula known as AREDS2 has been shown to reduce the risk of progressing to advanced AMD by approximately 25 percent. The formula contains vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin in precise doses. These supplements are not a treatment for early AMD and should only be taken if your eye doctor confirms you are at the right stage to benefit from them.

Anti-VEGF (vascular endothelial growth factor) injections are the primary treatment for wet AMD. These medications are delivered directly into the eye by a specialist and work by blocking the abnormal blood vessel growth that causes leaking and damage. Several anti-VEGF medications are available, including ranibizumab, aflibercept, bevacizumab, and faricimab. Faricimab, a newer bispecific antibody, allows some patients to be treated as infrequently as every four months. Starting treatment promptly after a wet AMD diagnosis gives the best chance of stabilizing or even improving vision.

Geographic atrophy is the advanced form of dry AMD in which patches of retinal cells are permanently lost. Two medications, pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay), were approved by the FDA to treat this condition. Both work by targeting the complement pathway, a part of the immune system involved in the cell damage seen in geographic atrophy. They are delivered by intravitreal injection, meaning directly into the eye, and have been shown to slow the growth of damaged areas, although they do not restore lost vision.

Living Well with AMD

Living Well with AMD

Managing AMD extends beyond the clinic. Daily habits, at-home monitoring, and the right support resources all play an important role in protecting your remaining vision and maintaining your quality of life.

Quitting smoking is the single most impactful change you can make if you currently smoke. Eating a Mediterranean-style diet rich in leafy greens, colorful vegetables, and fish supports retinal health. Regular physical activity, keeping blood pressure well controlled, and wearing sunglasses that block UV light are also beneficial habits at any stage of AMD.

Your eye doctor may recommend using an Amsler grid, a simple checkerboard pattern, to monitor your central vision between appointments. You check each eye separately, and if straight lines suddenly appear wavy, your vision becomes rapidly blurry, or a dark spot appears in your central vision, contact your eye doctor the same day. These changes can signal a conversion from dry to wet AMD, which requires urgent evaluation and treatment.

If AMD has already reduced your central vision, low vision specialists can provide practical tools and strategies to help you maintain independence. Magnifying devices, large-print options, improved lighting, and screen-reading technology are all part of a broader rehabilitation approach. Many people with AMD continue reading, cooking, and using technology with the right support in place, and your eye doctor can connect you with the appropriate services.

Frequently Asked Questions

Frequently Asked Questions

The questions below address common concerns that go beyond the basics, helping you make informed decisions about your care and know when to act quickly.

AMD frequently affects both eyes, but often at different rates and stages. Having AMD in one eye significantly increases the likelihood of developing it in the other, which is why your eye doctor monitors each eye independently at every visit. The Amsler grid can help you notice any differences between your two eyes between appointments.

No. It is normal for vision to change somewhat with age, including needing stronger reading glasses or adjusting to low light more slowly. AMD is a disease process involving drusen accumulation, retinal pigment damage, and in some cases abnormal blood vessel growth. These changes are distinctly different from the gradual, mild shifts that come with healthy aging, and not everyone who ages will develop AMD.

True AMD almost always occurs in people over 50. However, younger adults can develop other macular conditions that produce similar symptoms, such as Stargardt disease, a genetic condition, or myopic macular degeneration, which is associated with severe nearsightedness. If you are experiencing central vision changes at a younger age, your eye doctor can determine through imaging and examination whether you have AMD or a different macular condition that requires its own specific management.

Seek care the same day. Sudden distortion, a new dark spot, or rapid blurring in one eye can all indicate a shift from dry to wet AMD, which is a medical urgency. Anti-VEGF treatment works best when started quickly, and delays can result in greater permanent vision loss. Do not wait for your next scheduled appointment if something changes unexpectedly.

AMD affects central vision and, in severe cases, can cause legal blindness, which refers to vision loss significant enough to affect daily functioning. However, AMD does not damage peripheral vision, meaning most people retain enough side vision to navigate their environment independently. The goal of treatment is to preserve as much central vision as possible for as long as possible, which is why early detection and consistent monitoring matter so much.

While both conditions can cause central vision loss, they have different causes and require different treatments. AMD results from aging-related changes to the macula and involves drusen deposits and, in some cases, abnormal blood vessel growth. Diabetic retinopathy is caused by blood vessel damage from chronically high blood sugar and can affect the entire retina, not just the macula. A person can have both conditions at the same time, and each requires its own monitoring and treatment plan.

Schedule Your AMD Evaluation

Schedule Your AMD Evaluation

If you are over 50 or have risk factors such as a family history of AMD or a history of smoking, a comprehensive dilated eye exam is the most important step you can take for your long-term vision health. Our team is experienced in diagnosing and managing AMD at every stage, using the latest imaging technology and treatment options available. Early detection gives you the most choices and the best opportunity to protect your central vision for years to come. We are here to guide you through every step of your care.